Lorcaserin and metabolic disease: weight‐loss dependent and independent effects

Lorcaserin and metabolic disease: weight‐loss dependent and independent effects

Summary Objective Weight management pharmacotherapies can improve metabolic diseases through weight‐dependent and weight‐independent effects. Lorcaserin is a selective 5‐hydroxytryptamine 2C receptor agonist. The objective of this analysis is to quantify the relative contribution of weight loss to t...

Full description

Bibliographic Details
Main Authors: H. Bays, C. Perdomo, E. Nikonova, R. Knoth, M. Malhotra
Format: Article
Language:English
Published: Wiley 2018-12-01
Series:Obesity Science & Practice
Subjects:
Body weight
Metabolic disease
Obesity
Online Access:https://doi.org/10.1002/osp4.296

Similar Items

Similar Items